GleamWall
中文EN

SBRA Sabra Health Care REIT, Inc.

Real Estate Investment Trusts · Nasdaq · SEC CIK 1492298 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY23.4%
TTM net income YoY-59.2%
TTM EPS YoY-61.6%
Revenue 3-yr CAGR12.3%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin7.8%
FCF margin—
EBITDA margin—

Returns

ROE2.5%
ROA1.3%
ROIC (approx.)—
Asset turnover0.17x

Leverage & solvency

Liabilities / assets47.7%
Debt / equity0.86x
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income5.60x
Accruals ratio-6.0%
Payout ratio423.4%
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$249.56M$235.87M$221.75M$211.90M$190.04M$189.15M$183.54M$182.35M
SG&A expense$15.58M$16.82M$14.86M$15.91M$12.56M$12.51M$12.73M$13.03M
Interest expense$29.16M$29.78M$28.41M$28.94M$28.90M$27.55M$27.10M$28.08M
Pretax income$26.40M-$26.79M$39.43M$25.99M$21.73M$65.21M$40.50M$47.17M
Income tax$71,000$678,000$526,000$491,000$436,000$497,000$413,000$380,000
Net income$28.61M-$25.20M$40.88M$27.23M$22.54M$65.54M$40.30M$46.70M
EPS (basic)0.11-0.100.16—0.090.280.17—
EPS (diluted)0.11-0.100.16—0.090.270.17—
Dividends declared per share0.300.300.300.300.300.300.300.30
Weighted avg. shares (diluted)259.82M252.27M255.97M—243.56M240.93M240.30M—
Balance sheet
Cash & equivalents$36.24M$231.58M$116.53M$71.54M$207.52M$101.65M$28.90M$66.34M
Intangibles$87.18M$82.95M$67.41M$65.32M$59.81M$24.65M$24.82M$27.46M
Total assets$5.43B$5.51B$5.59B$5.49B$5.56B$5.33B$5.23B$5.30B
Long-term debt$2.44B$2.63B$2.67B$2.53B$2.59B$2.48B$2.39B$2.42B
Total debt$2.44B$2.63B$2.67B$2.53B$2.59B$2.48B$2.39B$2.42B
Total liabilities$2.59B$2.76B$2.80B$2.67B$2.74B$2.62B$2.53B$2.56B
Shareholders' equity$2.84B$2.75B$2.79B$2.82B$2.82B$2.71B$2.70B$2.74B
Net debt$2.40B$2.39B$2.55B$2.46B$2.38B$2.38B$2.37B$2.35B
Shares outstanding261.96M255.46M252.19M251.70M249.35M239.79M237.94M237.59M
Cash flow statement
Operating cash flow$128.97M$85.82M$98.36M$87.43M$99.96M$80.96M$80.26M$79.97M
Investing cash flow-$171.85M$86.50M-$105.09M-$116.55M-$199.84M-$45.13M-$16.44M$18.56M
Financing cash flow-$152.25M-$57.36M$52.10M-$100.89M$206.17M$36.73M-$101.24M-$100.96M
Depreciation & amortization$64.78M$56.38M$53.13M$51.41M$48.51M$43.59M$43.49M$42.31M
Stock-based compensation$3.92M$4.09M$3.10M$3.07M$2.88M$2.70M$2.71M$2.54M
Dividends paid$76.64M$75.66M$75.66M$74.81M$71.94M$71.38M$71.37M$70.98M

Free plan shows the latest 8 periods; Pro shows all 63 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.